PH16098A - Cyclohexane derivatives - Google Patents

Cyclohexane derivatives

Info

Publication number
PH16098A
PH16098A PH25103A PH25103A PH16098A PH 16098 A PH16098 A PH 16098A PH 25103 A PH25103 A PH 25103A PH 25103 A PH25103 A PH 25103A PH 16098 A PH16098 A PH 16098A
Authority
PH
Philippines
Prior art keywords
cyclohexane derivatives
cyclohexane
derivatives
Prior art date
Application number
PH25103A
Other languages
English (en)
Inventor
Hans Dr Bruderer
Albert Eduard Prof Dr Fischli
Rudolf Dr Pfister
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH16098A publication Critical patent/PH16098A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
PH25103A 1980-01-29 1981-01-20 Cyclohexane derivatives PH16098A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH72480A CH644580A5 (de) 1980-01-29 1980-01-29 Cyclohexen-derivate.

Publications (1)

Publication Number Publication Date
PH16098A true PH16098A (en) 1983-06-24

Family

ID=4193699

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25103A PH16098A (en) 1980-01-29 1981-01-20 Cyclohexane derivatives

Country Status (32)

Country Link
US (2) US4336268A (xx)
EP (1) EP0033156B1 (xx)
JP (1) JPS56120650A (xx)
KR (6) KR850000626B1 (xx)
AR (1) AR227906A1 (xx)
AT (2) ATE9895T1 (xx)
AU (1) AU540697B2 (xx)
BR (1) BR8100484A (xx)
CA (1) CA1161064A (xx)
CH (1) CH644580A5 (xx)
CS (6) CS219940B2 (xx)
DE (2) DE3102603A1 (xx)
DK (1) DK15681A (xx)
ES (6) ES8301200A1 (xx)
FI (1) FI801147A (xx)
FR (1) FR2479815A1 (xx)
GB (1) GB2068373B (xx)
HU (1) HU182280B (xx)
IE (1) IE50885B1 (xx)
IL (1) IL61961A (xx)
IT (1) IT1135001B (xx)
LU (1) LU83096A1 (xx)
MC (1) MC1365A1 (xx)
NL (1) NL8100403A (xx)
NO (1) NO149958C (xx)
NZ (1) NZ196086A (xx)
PH (1) PH16098A (xx)
PT (1) PT72415B (xx)
SE (1) SE8100403L (xx)
YU (1) YU332180A (xx)
ZA (1) ZA81459B (xx)
ZW (1) ZW31480A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US6569887B2 (en) 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
BRPI0613943B1 (pt) 2005-07-27 2021-06-22 Otsuka America Pharmaceutical, Inc Composto, composição farmacêutica o compreendendo, usos de um composto e de uma composição farmacêutica, bem como composição neurobiologicamente ativa
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US20080269348A1 (en) * 2006-11-07 2008-10-30 Phil Skolnick Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
US20090069374A1 (en) * 2007-06-06 2009-03-12 Phil Skolnick Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH249047A (de) * 1944-03-20 1947-05-31 Ag J R Geigy Verfahren zur Darstellung eines basischen Esters einer 1-Aryl-cycloalkyl-1-carbonsäure.
CH249052A (de) * 1944-03-20 1947-05-31 Ag J R Geigy Verfahren zur Darstellung eines basischen Amids einer 1-Aryl-cycloalkyl-1-carbonsäure.
US2647122A (en) * 1948-10-01 1953-07-28 Sterling Drug Inc Tertiary amines and process of preparing them
US3109845A (en) * 1960-02-04 1963-11-05 Thomae Gmbh Dr K 1-cyclohexyl, 1-cyclohexenyl, 1-furyl, and 1-thienyl, tertiary amino substituted methanes
DE1518545A1 (de) * 1965-04-01 1970-01-15 Boehringer Mannheim Gmbh Verfahren zur Herstellung neuer Phenylcyclohexylalkylamine und ihrer Salze
DE1518663A1 (de) * 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3408396A (en) * 1965-10-22 1968-10-29 Colgate Palmolive Co alpha-cyclohexyl-3, 4-disubstituted-phenyl acetamides
US3485873A (en) * 1966-12-21 1969-12-23 Sterling Drug Inc N-benzyl-n-methyl-omega-phenyl-omega-cycloalkyl-lower-alkylamines
US3737451A (en) * 1970-09-23 1973-06-05 Sandoz Ag Cis-3,4-diaryl-cyclopentylidene-and 1-cyclopentene-1-acetic acids and derivatives
US4053637A (en) * 1971-06-11 1977-10-11 Astra Lakemedal Aktiebolag Compounds of diphenylcyclopentylamine type and methods for their uses
CA1130318A (en) * 1978-10-11 1982-08-24 Peter M. Muller Cyclohexadiene derivatives

Also Published As

Publication number Publication date
LU83096A1 (de) 1982-09-10
PT72415B (en) 1982-07-26
DK15681A (da) 1981-07-30
ES506686A0 (es) 1982-12-16
IE50885B1 (en) 1986-08-06
PT72415A (en) 1981-02-01
NL8100403A (nl) 1981-08-17
KR840001552B1 (ko) 1984-10-05
ES506684A0 (es) 1983-10-16
ATE9895T1 (de) 1984-11-15
FR2479815B1 (xx) 1984-02-17
AU6671981A (en) 1981-08-06
GB2068373B (en) 1983-11-30
AU540697B2 (en) 1984-11-29
IT8119047A0 (it) 1981-01-08
CS219944B2 (en) 1983-03-25
EP0033156A2 (de) 1981-08-05
CS219941B2 (en) 1983-03-25
US4336268A (en) 1982-06-22
ES8400079A1 (es) 1983-10-16
CS219943B2 (en) 1983-03-25
NO149958C (no) 1984-07-25
MC1365A1 (fr) 1981-10-23
KR840001554B1 (ko) 1984-10-05
ES8301884A1 (es) 1982-12-16
DE3166656D1 (en) 1984-11-22
AR227906A1 (es) 1982-12-30
ES498866A0 (es) 1982-12-01
KR850000626B1 (ko) 1985-05-06
CS219942B2 (en) 1983-03-25
ES506688A0 (es) 1982-12-16
ES8301885A1 (es) 1982-12-16
ES506687A0 (es) 1982-12-16
IL61961A (en) 1984-05-31
KR840001553B1 (ko) 1984-10-05
KR850002003A (ko) 1985-04-10
FI801147A (fi) 1981-07-30
ES8301878A1 (es) 1982-12-16
ATA35581A (de) 1984-05-15
ES8301200A1 (es) 1982-12-01
NO149958B (no) 1984-04-16
ES8301883A1 (es) 1982-12-16
ZW31480A1 (en) 1981-09-02
NO810297L (no) 1981-07-30
ES506685A0 (es) 1982-12-16
IE810153L (en) 1981-07-29
SE8100403L (sv) 1981-07-30
CH644580A5 (de) 1984-08-15
KR830005105A (ko) 1983-07-23
IL61961A0 (en) 1981-02-27
EP0033156B1 (de) 1984-10-17
YU332180A (en) 1983-10-31
US4448991A (en) 1984-05-15
GB2068373A (en) 1981-08-12
CS219940B2 (en) 1983-03-25
IT1135001B (it) 1986-08-20
KR850000627B1 (ko) 1985-05-06
ZA81459B (en) 1982-02-24
BR8100484A (pt) 1981-08-18
AT376654B (de) 1984-12-27
CA1161064A (en) 1984-01-24
NZ196086A (en) 1984-08-24
EP0033156A3 (en) 1982-03-17
CS220347B2 (en) 1983-03-25
KR840001551B1 (ko) 1984-10-05
HU182280B (en) 1983-12-28
FR2479815A1 (fr) 1981-10-09
JPS56120650A (en) 1981-09-22
DE3102603A1 (de) 1981-12-10

Similar Documents

Publication Publication Date Title
GB2079270B (en) Imidazo-rifamycin derivatives
MY8600354A (en) N-arylbenzamide derivatives
GB2086380B (en) L-argininal derivatives
PH17950A (en) Pyrimiodone derivatives
PH16098A (en) Cyclohexane derivatives
GB2083462B (en) 2-thiopenem derivatives
GB2067989B (en) Bis-moranoline derivatives
GB2075499B (en) Nonaprenylamine derivatives
PH16930A (en) Phenoxy-aminopropanol derivatives
GB8324990D0 (en) 3-aminopropoxyphenyl derivatives
GB2088379B (en) 1-phenethylimidazole derivatives
GB2085882B (en) Aprosamine derivatives
GB2076815B (en) Aminophenylpyridine derivatives
GB2076395B (en) Nonaprenylamine derivatives
GB2074165B (en) Nonaprenylamine derivatives
GB2070589B (en) 7a1methoxycephalospin derivatives
GB2073201B (en) Steroid-spiro-oxathiazolidine derivatives
GB2069998B (en) Benzenethiocarbamate derivatives
IE801216L (en) Benzothienothiazine derivatives
IE802456L (en) Imidazole-pyridine derivatives
IE800957L (en) Fluorinated-triazolyl-butane derivatives
IE801572L (en) Thiadiazocine derivatives
IE801748L (en) Sulphonylisourea derivatives
IE801950L (en) Pyridazopyridazine derivatives
IE802018L (en) Oxayohimbane derivatives